Cue Biopharma
47 hedge funds and large institutions have $11.9M invested in Cue Biopharma in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Holders
47
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.27M | |
| 2 | +$1.24M | |
| 3 | +$594K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$158K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$105K |
Top Sellers
| 1 | -$185K | |
| 2 | -$127K | |
| 3 | -$117K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$107K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$43.7K |
